The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Children who have taken psychostimulants long term for attention deficit/hyperactivity disorder (ADHD) are now presenting at adult psychiatry clinics at an age at which bipolar disorder and schizophrenia may first appear and at which pregnancy is a possibility. Doctors who may have little experience in the management of ADHD or use of psychostimulants are faced with decisions on whether to continue or withdraw medication. A literature search conducted to clarify these issues revealed that, although psychostimulants are generally efficacious in ADHD, the risks of withdrawal reactions and of possible long-term effects such as drug addiction, psychosis and depression, or effects in pregnancy, have not been adequately investigated. In particular, there is little information on the effects of withdrawal and no firm guidelines on methods of psychostimulant discontinuation. There is a need for further research to clarify the pharmacological issues involved in the drug treatment of ADHD and for overlapping arrangements between child and adult psychiatry clinics in the management of ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As discussed earlier, the use of stimulants continues to be hampered by stigma and lack of up to date information in their use, with restricted access in many European countries [279].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [279]
Citations
Cites
1 retracted
Niederhofer, H., Staffen, W., & Mair, A. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001714 · Cited by 21 · cited 1×
“There have been several studies with alpha2 adrenoceptor agonists including clonidine, guanfacine and lofexidine (Niederhofer et al., 2003).”
BackgroundRetractedBrain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552 · cited 2×
“MRI studies reveal that white matter increases linearly during childhood and adolescence while grey matter changes are non-linear and regionally specific (Giedd et al., 1999).”
BackgroundMolecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · cited 1×
“Several further genes implicated in ADHD (reviewed by DiMaio et al., 2003; Faraone et al., 2005; Madras et al., 2005) include the noradrenaline transporter, D4 and D5 dopamine receptors, dopamine beta-hydroxylase and synaptosomal-associated protein-25 and others.”
BackgroundCastellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646 · cited 1×
“An MRI study of 152 children and adolescents (aged 5–18 years) with ADHD and 139 matched controls was reported by Castellanos et al. (2002).”
Attention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463 · cited 4×
“Similarly, neuropsychological studies have implicated abnormalities of frontal cortical regions and the circuits linking them to the basal ganglia and cerebellum in ADHD (Giedd et al., 2001; Raz, 2004; Biederman and Faraone, 2005).”
BackgroundInfluentialNeuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950 · cited 1×
“These difficulties can be severe enough to disrupt everyday life and adults with ADHD tend to have work problems, driving violations, automobile collisions and high rates of separation and divorce (Biederman et al., 1993; Papazian et al., 2002; Wilens et al., 2004).”
BackgroundPsychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition
Sonuga-Barke, E. J. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00432-6 · Cited by 901 · cited 1×
“Apparently consistent with the finding that the high-risk dopamine transporter allele is linked only with hyperactive/impulsive but not inattentive symptoms in ADHD (Waldman et al., 1998), Sonuga-Barke (2002) suggested that there are two types of ADHD, which may be combined in the severe form (HKD).”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885 · cited 1×
“…emission tomography studies have shown increased synaptic dopamine concentration in the human brain after oral administration of methylphenidate within the therapeutic range (Volkow et al., 2001), and methylphenidate appears to be slightly more potent than cocaine (Volkow et al., 1998, 1999b).”
BackgroundWilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Research works printed but not linked: 18
- American Pregnancy Association, 2005, Using illegal street drugs during pregnancy
- 10.1037/0033-2909.121.1.65 · doi:10.1037/0033-2909.121.1.65 · Paper page
- Biederman J, 2004, Primary Psychiatry, 11, 57
- Cohen D, 2002, Ethical Human Sciences and Services, 4, 189
- DiMaio S, 2003, J Psychiatry Neurosci, 28, 27
- Ferner R E, 1998, Textbook of Adverse Drug Reactions, 82
- Harpin V, 2005, Prescriber, 16, 12
- MHRA Press Release Medical and Health Care Products Agency, 2005, Updated warnings on the risk of suicidal thoughts with Strattera
- Miller N S, 1991, Comprehensive Handbook of Drug and Alcohol Addiction, 427
- 10.1089/cap.2004.14.418 · doi:10.1089/cap.2004.14.418 · Paper page
- National Institute for Clinical Excellence (NICE), 2003, Guidelines on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood
- Prescriber, 2005, Prescriber, 16, 10
- 10.1016/S0140-6736(05)70271-3 · doi:10.1016/s0140-6736(05)70271-3 · Paper page
- Scottish Intercollegiate Guidelines Network, 2001, SIGN, 52
- Sevecke K, 2005, Der Nervenarzt
- Shetty H G M, 1998, Textbook of Adverse Drug Reactions, 541
- Surles L K, 2002, J Am Board Fam Pract, 15, 498
- Wilens T E, 2004, Primary Psychiatry, 11, 63
Cited by
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“As discussed earlier, the use of stimulants continues to be hampered by stigma and lack of up to date information in their use, with restricted access in many European countries [279].”
Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073219 · Cited by 259
“Various concerns have been raised over long-term treatment effects, including the potential for tolerance over time, and adverse effects of psychostimulants such as psychosis, sensitization, dependency and withdrawal reactions (Ashton et al., 2006).”
BackgroundSikirica, V., Lu, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 206
Koesters, M., Becker, T., Kilian, R., Fegert, J., & Weinmann, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108092338 · Cited by 142
Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register‐based study
Hærvig, K. K., Mortensen, L. H., Hansen, A. V., & Strandberg‐Larsen, K. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3600 · Cited by 82
Metadata
- Authors
- Ashton, H., Gallagher, P., & Moore, B.
- Affiliations
- Newcastle University (GB)
- ORCID
- Gallagher, Peter
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-09
- Volume
- 20
- Issue
- 5
- Pages
- 602-610
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2087008462
- Cited by
- 31
- References
- 101
- Citations by year
- 2021: 1 · 2020: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Association for Psychopharmacology
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- attention deficit hyperactivity disorder, psychostimulants, drug withdrawal, bipolar disorder, schizophrenia, pregnancy, drug addiction, psychosis, depression, adult psychiatry, child psychiatry
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Child, Female, Humans, Pregnancy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. https://app.cochat.ai/papers/10.1177/0269881106061710
- The paper
- Ashton, H., Gallagher, P., & Moore, B. (2006). The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. Journal of Psychopharmacology. https://doi.org/10.1177/0269881106061710
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.